Prioritizing Patients: Dr. Pemmaraju’s MPN Highlights From ASCO 2019

Published on

Topics include: Treatments

Thousands of oncology professionals gathered from around the world at the 2019 American Society of Clinical Oncology (ASCO) meeting in Chicago with the theme for this year’s event being “caring for every patient, learning from every patient.” How are researchers going beyond the scientific breakthroughs in cancer care? Watch as leading myeloproliferative neoplasms (MPN) specialist Dr. Naveen Pemmaraju, from The University of Texas MD Anderson Cancer Center, discusses what a patient-centered approach looks like and what’s on the radar in MPN treatment developments.

View more programs featuring and

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

So, Dr. Pemmaraju, tell us, why are you here at ASCO, and why is it important?  

And so I think the biggest takeaway I can bring is I think it recenters it back on a patient-focused patient-centered approach, begin, middle, ending, all about our patients. And if you do that, for example, like Ruben Mesa did with the symptom burden scale in MPNs, that speaks to a lot of our viewers, then you can always guide your research, good days and bad days, negative data, positive data, it's always about the patient.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

ASH 2018 Daily Wrap: MPN News

On location in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

Woman With Myelofibrosis Gets Unapproved Drug With Help of Care Team

How can you advocate for yourself with a clinical trial drug if it’s later taken away? Watch as Sandra Dillon shares her story of her fedratinib trial.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on August 27, 2019